PureTech Health plc (PRTC.L)
GBp 164.0
(2.5%)
GBp 164.0
(2.5%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -65.69 Million USD | -77.25% |
| 2022 | -37.06 Million USD | 40.9% |
| 2021 | -62.7 Million USD | -1472.79% |
| 2020 | 4.56 Million USD | -98.92% |
| 2019 | 421.14 Million USD | 696.02% |
| 2018 | -70.65 Million USD | 0.05% |
| 2017 | -70.69 Million USD | -44.89% |
| 2016 | -48.79 Million USD | -23.86% |
| 2015 | -39.39 Million USD | 5.4% |
| 2014 | -41.64 Million USD | -867.77% |
| 2013 | -4.3 Million USD | 61.07% |
| 2012 | -11.05 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -20.88 Million USD | 0.0% |
| 2024 Q1 | -20.88 Million USD | -2.65% |
| 2023 Q3 | -20.34 Million USD | -62.75% |
| 2023 Q4 | -20.34 Million USD | 0.0% |
| 2023 Q1 | -12.5 Million USD | -13.6% |
| 2023 Q2 | -12.5 Million USD | 0.0% |
| 2023 FY | -65.69 Million USD | -77.25% |
| 2022 Q1 | -14.17 Million USD | -291.04% |
| 2022 FY | -37.06 Million USD | 40.9% |
| 2022 Q4 | -11 Million USD | 0.0% |
| 2022 Q3 | -11 Million USD | 22.35% |
| 2022 Q2 | -14.17 Million USD | 0.0% |
| 2021 Q2 | -37.69 Million USD | 0.0% |
| 2021 FY | -62.7 Million USD | -1472.79% |
| 2021 Q4 | 7.41 Million USD | 0.0% |
| 2021 Q3 | 7.41 Million USD | 119.68% |
| 2021 Q1 | -37.69 Million USD | 36.09% |
| 2020 Q1 | 61.97 Million USD | -64.34% |
| 2020 FY | 4.56 Million USD | -98.92% |
| 2020 Q2 | 61.97 Million USD | 0.0% |
| 2020 Q3 | -58.98 Million USD | -195.17% |
| 2020 Q4 | -58.98 Million USD | 0.0% |
| 2019 Q1 | 36.75 Million USD | 302.28% |
| 2019 Q3 | 173.81 Million USD | 372.94% |
| 2019 Q4 | 173.81 Million USD | 0.0% |
| 2019 Q2 | 36.75 Million USD | 0.0% |
| 2019 FY | 421.14 Million USD | 696.02% |
| 2018 Q4 | -18.16 Million USD | 0.0% |
| 2018 FY | -70.65 Million USD | 0.05% |
| 2018 Q3 | -18.16 Million USD | -396.77% |
| 2018 Q2 | -3.65 Million USD | 0.0% |
| 2018 Q1 | -3.65 Million USD | -110.65% |
| 2017 Q3 | 34.33 Million USD | 262.74% |
| 2017 FY | -70.69 Million USD | -44.89% |
| 2017 Q2 | -21.09 Million USD | 0.0% |
| 2017 Q1 | -21.09 Million USD | -124.57% |
| 2017 Q4 | 34.33 Million USD | 0.0% |
| 2016 Q4 | -9.39 Million USD | 0.0% |
| 2016 FY | -48.79 Million USD | -23.86% |
| 2016 Q2 | -15 Million USD | 0.0% |
| 2016 Q1 | -15 Million USD | -1.75% |
| 2016 Q3 | -9.39 Million USD | 37.38% |
| 2015 Q3 | -14.74 Million USD | -197.71% |
| 2015 Q2 | -4.95 Million USD | 0.0% |
| 2015 Q1 | -4.95 Million USD | 60.76% |
| 2015 FY | -39.39 Million USD | 5.4% |
| 2015 Q4 | -14.74 Million USD | 0.0% |
| 2014 Q2 | -8.19 Million USD | 0.0% |
| 2014 Q1 | -8.19 Million USD | 56.81% |
| 2014 FY | -41.64 Million USD | -867.77% |
| 2014 Q4 | -12.62 Million USD | 0.0% |
| 2014 Q3 | -12.62 Million USD | -53.95% |
| 2013 FY | -4.3 Million USD | 61.07% |
| 2013 Q1 | -1.39 Million USD | 0.0% |
| 2013 Q3 | -1.39 Million USD | 0.0% |
| 2013 Q2 | -1.39 Million USD | 0.0% |
| 2013 Q4 | -18.98 Million USD | -1260.01% |
| 2012 Q3 | -2.82 Million USD | 0.0% |
| 2012 Q2 | -2.82 Million USD | 0.0% |
| 2012 Q1 | -2.82 Million USD | 0.0% |
| 2012 FY | -11.05 Million USD | 0.0% |
| 2012 Q4 | -1.39 Million USD | 50.65% |
| 2011 Q4 | -2.82 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|